Viewing nowCombinationTenegliptin Sustained Release Tablet 10/500 mg
Metformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.

MFDS item code 202202639 · Approved 2022.06.27 · Insurance code 671707060
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. When taken alongside diet and exercise, it can help manage blood sugar levels more effectively. In particular, the combination of Tenegliptin and Metformin helps improve blood sugar control. Therefore, it is advisable to use this medication for diabetes management.
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. In patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release metformin to the extended-release formulation, blood glucose control should be closely monitored and the dose adjusted appropriately. When administered concomitantly with a sulfonylurea, consider reducing the sulfonylurea dose to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to this medicine from other antihyperglycemic agents. Because any change may cause changes in blood glucose control, changes in treatment for patients with type 2 diabetes should be made under close monitoring. To preserve the extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing.
This medication is used to treat diabetes but can rarely cause a serious condition called lactic acidosis. Lactic acidosis occurs when there is a dangerous buildup of lactic acid in the body, and if symptoms appear, medical attention should be sought immediately. This medication should not be administered to patients with moderate to severe renal impairment, and it is also not safe for patients with cardiovascular issues such as heart failure or acute myocardial infarction. Additionally, when undergoing exams with iodinated contrast agents, this medication should be stopped 48 hours prior to the exam, and should only be resumed once normal kidney function is confirmed. Women who are pregnant or may become pregnant, patients with severe liver impairment, and those with severe infections or traumatic systemic disorders are also advised against using this medication. When used in conjunction with insulin or sulfonylureas, there is an increased risk of hypoglycemia, so patients should be well-informed about the symptoms of hypoglycemia and take appropriate actions if symptoms occur. During treatment, it is essential to regularly monitor kidney function, especially in elderly patients or those with reduced kidney function. Furthermore, alcohol consumption should be avoided as it may increase the risk of lactic acidosis. Side effects can include gastrointestinal disturbances, dizziness, skin rashes, and joint pain. If serious side effects such as acute pancreatitis or interstitial pneumonia are suspected, medical advice should be sought immediately. Patients scheduled for surgery should discontinue this medication 48 hours prior to the procedure and can only resume once normal kidney function is confirmed after the surgery. If symptoms such as sudden abdominal pain, vomiting, difficulty breathing, or weakness occur during treatment, the physician should be notified immediately, as these may signal serious side effects. This medication has not established safety and efficacy in children and should not be used in nursing women.
Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, intestinal obstruction, liver dysfunction, interstitial pneumonia, pemphigoid, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyp, colonic polyp, duodenal ulcer, gastroesophageal reflux disease, diarrhea, decreased appetite, elevated amylase, elevated lipase, increased AST (GOT), increased ALT (GPT), elevated GGT, increased ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, pruritus, allergic dermatitis, arthralgia, elevated CK (CPK), increased serum potassium concentration, fatigue, allergic rhinitis, increased serum uric acid, peripheral edema, herpes zoster, limb pain, upper abdominal pain, gastritis, upper respiratory tract infection, tremors, headache, asthenia, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory tract infection, rhinitis, cold sweat, diabetic retinopathy, vision impairment, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, diarrhea, chronic gastritis, irritable bowel syndrome, fatigue, cerebral infarction, hyperglycemia, liver biopsy, decreased neutrophil count, abnormal blood glucose, increased blood glucose, increased blood pressure, hepatic coma, lumbar spinal stenosis, intervertebral disc protrusion in the spine, intervertebral disc disorder in the spine, spinal ligament ossification, spinal foraminal stenosis, rotator cuff syndrome, bladder tumor, ureterolithiasis, urolithiasis, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyp, gastritis, biliary obstruction, chronic cholecystitis, soft tissue inflammation, pneumonia, cataract, depression, iliac artery stenosis, vertigo, benign prostatic hyperplasia, knee surgery, vomiting, gastrointestinal motility disorder, decreased gastrointestinal motility, enteritis, toothache, anal rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, hemorrhage, chest discomfort, fever, chills, systemic edema, injection site inflammation, dysuria, renal cyst, nocturia, ovarian cyst, vulvar pruritus, menopausal symptoms, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid injury, ligament sprain, lip injury, contusion, urticaria, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, primary hyperparathyroidism, angina, otalgia, iron deficiency anemia, food allergy, pressure ulcer
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It should also be kept away from extreme temperatures, ideally at room temperature between 1 and 30 degrees Celsius.
Orange oval shaped sustained release film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication · Combination
LightPharm Tech Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.